ServiceNow Reveals a New Challenge From the Iran War: Deal Delays

ServiceNow said the Iran war caused a 75 basis-point revenue headwind from delayed large government on-premise deal closings in the Middle East, and shares fell 12% after hours. The company beat estimates and raised full-year subscription revenue guidance, but lowered adjusted operating margin guidance to 31.5% from 32% and missed billings expectations. IBM also flagged the war as a drag on guidance, underscoring broader earnings-season uncertainty for software stocks.

Analysis

The market is starting to price a second-order effect that matters more than the headline: geopolitical shocks are no longer just an energy-input story, they are a deal-cycle story for enterprise software. When large public-sector or quasi-public contracts slip, the earnings hit is disproportionately concentrated because the revenue is high-margin, lumpy, and often booked upfront; that means even a modest delay can distort near-term growth optics and compress valuation multiples faster than the underlying demand picture changes. The key read-through is that guidance risk may broaden from isolated Middle East exposure into a broader “execution under uncertainty” discount across software names with big-ticket, long-duration sales cycles.

The immediate losers are companies with mixed cloud/on-prem monetization and outsized exposure to government or infrastructure spending in the region. IBM’s posture is important because it suggests management teams may choose to preserve credibility by holding guidance rather than leaning into upside, which tends to cap multiple expansion for the whole group. If this pattern repeats, expect investors to punish billings misses more than revenue misses over the next 1-2 quarters, since billings becomes the cleanest early warning signal that procurement delays are spreading beyond one-off disruptions.

The contrarian point: the move may be more about timing than demand destruction. If these are truly deferred rather than cancelled deals, the revenue could reappear over the next 2-3 quarters, creating a sharp rebound in reported growth once macro clarity improves. That sets up a classic overreaction window where the market may be extrapolating a one-quarter political delay into a structural slowdown, especially for vendors with sticky installed bases and mission-critical workflows.

For the broader software complex, the better framework is not “war hurts SaaS” but “war raises the hurdle rate for long-duration software contracts.” That should favor faster-payback software, consumption-based models, and vendors with low reliance on discretionary public-sector budgets, while pressuring names where a handful of enterprise closes can swing quarterly growth by several hundred basis points. AI disruption remains the background risk, but near term the more tradable issue is whether geopolitical uncertainty forces customers to defer transformation projects and procurement decisions.

Key Decisions for Investors

• Short NOW on a 2-6 week horizon into earnings-related volatility; use a tight stop on any evidence that delayed government deals reclose faster than expected. Risk/reward favors downside continuation if billings and margin guide-downs keep driving multiple compression.
• Pair trade: long lower-duration, consumption-based software vs short legacy enterprise software with large deal concentration and government exposure over the next 1-2 quarters. The thesis is that the market will pay up for revenue visibility and penalize lumpy booking risk.
• Buy NOW puts or put spreads 1-2 earnings cycles out if the stock retraces into pre-gap levels; use the structure to limit premium bleed while betting that guidance uncertainty keeps the multiple capped.
• For IBM, fade strength rather than chase the post-earnings dip: a short-term sell/hold stance is justified until management demonstrates that Middle East uncertainty is not broadening into a full-year guide limitation. Best used as a relative short versus higher-quality software peers.
• Watch for a re-entry opportunity in NOW only after two confirmations: billings inflect back above consensus and management quantifies delayed deals as timing, not demand loss. That would make the current selloff look like an overreaction and open a 3-6 month mean-reversion trade.